FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edward Cone

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Edward J Cone; Rebecca Heltsley; Charles P Lodico; John M Mitchell; David L Black; Ronald R Flegel
Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Brandi Puet; David L Black; Yale H Caplan; Anne DePriest; Rebecca Heltsley; Julie Knight; Edward J Cone
Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
Sandra D Comer; Edward J Cone; Penney Cowan; Robert H Dworkin; John T Farrar; Richard W Foltin; Jennifer Haythornthwaite; Sharon Hertz; Donald R Jasinski; Gary W Jay; Chris-Ellyn Johanson; Roderick Junor; Nathaniel P Katz; Michael Klein; Ernest A Kopecky; Deborah B Leiderman; Michael P McDermott; Charles O'Brien; Alec B O'Connor; Pamela P Palmer; Srinivasa N Raja; Bob A Rappaport; Christine Rauschkolb; Michael C Rowbotham; Cristina Sampaio; Edward M Sellers; Beatrice Setnik; Marta Sokolowska; JOSEPH STAUFFER; Dennis C Turk; Edgar H Adams; Robert Balster; George E Bigelow; Laurie B Burke; Igor Cerny; Robert D Colucci; James P Zacny; J David Haddox; Sharon L Walsh
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edward Cone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Edward J Cone; Rebecca Heltsley; Charles P Lodico; John M Mitchell; David L Black; Ronald R Flegel
Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Journal of analytical toxicology 2013;37(5):255-64.
2013: Brandi Puet; David L Black; Yale H Caplan; Anne DePriest; Rebecca Heltsley; Julie Knight; Edward J Cone
Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
Journal of analytical toxicology 2013;37(1):1-4.
2012: Sandra D Comer; Edward J Cone; Penney Cowan; Robert H Dworkin; John T Farrar; Richard W Foltin; Jennifer Haythornthwaite; Sharon Hertz; Donald R Jasinski; Gary W Jay; Chris-Ellyn Johanson; Roderick Junor; Nathaniel P Katz; Michael Klein; Ernest A Kopecky; Deborah B Leiderman; Michael P McDermott; Charles O'Brien; Alec B O'Connor; Pamela P Palmer; Srinivasa N Raja; Bob A Rappaport; Christine Rauschkolb; Michael C Rowbotham; Cristina Sampaio; Edward M Sellers; Beatrice Setnik; Marta Sokolowska; JOSEPH STAUFFER; Dennis C Turk; Edgar H Adams; Robert Balster; George E Bigelow; Laurie B Burke; Igor Cerny; Robert D Colucci; James P Zacny; J David Haddox; Sharon L Walsh
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.
Pain 2012;153(12):2315-24.
2012: Aldo Polettini; Edward J Cone; David A Gorelick; Marilyn A Huestis
Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration.
Analytica chimica acta 2012;726():35-43.
2012: J Michael Walsh; Edward J Cone; Dennis J Crouch; Yale H Caplan
Is THC-COOH a useful determinant for passive inhalation in oral fluid THC testing?
Journal of analytical toxicology 2012;36(4):291.
2012: Rebecca Heltsley; Lucas Marshall; Viola M Meadors; Tim Robert; David L Black; Yale H Caplan; Dennis J Crouch; Anne Depriest; Edward J Cone
Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.
Journal of analytical toxicology 2012;36(2):75-80.
2012: Edward J Cone
Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
Forensic science international 2012;215(1-3):88-91.
2011: Rebecca Heltsley; Lucas Marshall; Viola M Meadors; Tim Robert; David L Black; Yale H Caplan; Anne DePriest; Edward J Cone
Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
Journal of analytical toxicology 2011;35(8):529-40.
2011: Rebecca Heltsley; Tim Robert; David L Black; Yale H Caplan; Anne Depriest; Edward J Cone
Urine drug testing of chronic pain patients. IV. prevalence of gabapentin and pregabalin.
Journal of analytical toxicology 2011;35(6):357-9.
2011: Edward J Cone; Yale H Caplan
Re: Pergolizzi et al., 2010: the role of urine drug testing for patients on opioid therapy.
Pain practice : the official journal of World Institute of Pain 2011;11(3):309; author reply 310.
2011: Dean Fritch; Kristen Blum; Sheena Nonnemacher; Keith Kardos; August R Buchhalter; Edward J Cone
Barbiturate detection in oral fluid, plasma, and urine.
Therapeutic drug monitoring 2011;33(1):72-9.
2010: Anne Depriest; Rebecca Heltsley; Frank Moser; Tim Robert; David L Black; Yale H Caplan; Beverly Cawthon; Edward J Cone
Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use.
Journal of analytical toxicology 2010;34(8):444-9.
2010: Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.
Therapeutic drug monitoring 2010;32(5):628-37.
2010: Edward J Cone; Anne Zichterman; Rebecca Heltsley; David L Black; Beverly Cawthon; Tim Robert; Frank Moser; Yale H Caplan
Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
Forensic science international 2010;198(1-3):58-61.
2010: Michael L Smith; Eric Shimomura; Buddha D Paul; Edward J Cone; W David Darwin; Marilyn A Huestis
Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine.
Journal of analytical toxicology 2010;34(2):57-63.
2010: Rebecca Heltsley; Anne Zichterman; David L Black; Beverly Cawthon; Tim Robert; Frank Moser; Yale H Caplan; Edward J Cone
Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
Journal of analytical toxicology 2010;34(1):32-8.
2009: Dean Fritch; Kristen Blum; Sheena Nonnemacher; Brenda J Haggerty; Matthew P Sullivan; Edward J Cone
Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 2009;33(9):569-77.
2009: Edward J Cone; Yale H Caplan
Urine toxicology testing in chronic pain management.
Postgraduate medicine 2009;121(4):91-102.
2009: David L Black; Beverly Cawthon; Tim Robert; Frank Moser; Yale H Caplan; Edward J Cone
Multiple drug ingestion by ecstasy abusers in the United States.
Journal of analytical toxicology 2009;33(3):143-7.
2009: Edward J Cone; Yale H Caplan; Frank Moser; Tim Robert; Melinda K Shelby; David L Black
Normalization of urinary drug concentrations with specific gravity and creatinine.
Journal of analytical toxicology 2009;33(1):1-7.
2009: Saul Shiffman; Edward J Cone; August R Buchhalter; Jack E Henningfield; Jeffrey Rohay; Joe G Gitchell; John M Pinney; Tommy Chau
Rapid absorption of nicotine from new nicotine gum formulations.
Pharmacology, biochemistry, and behavior 2009;91(3):380-4.
2008: Jenna M Chin; Michele L Merves; Bruce A Goldberger; Angela Sampson-Cone; Edward J Cone
Caffeine content of brewed teas.
Journal of analytical toxicology 2008;32(8):702-4.
2008: Edward J Cone; Yale H Caplan; David L Black; Timothy Robert; Frank Moser
Urine drug testing of chronic pain patients: licit and illicit drug patterns.
Journal of analytical toxicology 2008;32(8):530-43.
2008: Amanda J Jenkins; Edward J Cone
Time of heroin use.
Journal of analytical toxicology 2008;32(6):454-6.
2008: Edward J Cone; Yale H Caplan; Frank Moser; Tim Robert; David Black
Evidence that morphine is metabolized to hydromorphone but not to oxymorphone.
Journal of analytical toxicology 2008;32(4):319-23.
2008: Allan J Barnes; Michael L Smith; Sherri L Kacinko; Eugene W Schwilke; Edward J Cone; Eric T. Moolchan; Marilyn A Huestis
Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.
Clinical chemistry 2008;54(1):172-80.
2007: Marilyn A Huestis; William D Darwin; Eric Shimomura; Shairose A Lalani; Daniel V Trinidad; Amanda J Jenkins; Edward J Cone; Aaron J Jacobs; Michael L Smith; Buddha D Paul
Cocaine and metabolites urinary excretion after controlled smoked administration.
Journal of analytical toxicology 2007;31(8):462-8.
2007: Edward J Cone; Joe Clarke; Lolita Tsanaclis
Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Journal of analytical toxicology 2007;31(8):424-33.
2007: Marilyn A Huestis; Edward J Cone
Methamphetamine disposition in oral fluid, plasma, and urine.
Annals of the New York Academy of Sciences 2007;1098():104-21.
2007: Edward J Cone; Marilyn A Huestis
Interpretation of oral fluid tests for drugs of abuse.
Annals of the New York Academy of Sciences 2007;1098():51-103.
2006: Rachel R McCusker; Brian Fuehrlein; Bruce A Goldberger; Mark S Gold; Edward J Cone
Caffeine content of decaffeinated coffee.
Journal of analytical toxicology 2006;30(8):611-3.
2006: Erin A Kolbrich; Allan J Barnes; David A Gorelick; Susan J Boyd; Edward J Cone; Marilyn A Huestis
Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration.
Journal of analytical toxicology 2006;30(8):501-10.
2006: Rebecca A Jufer; Sharon L Walsh; Edward J Cone; Angela Sampson-Cone
Effect of repeated cocaine administration on detection times in oral fluid and urine.
Journal of analytical toxicology 2006;30(7):458-62.
2006: Eugene W Schwilke; Allan J Barnes; Sherri L Kacinko; Edward J Cone; Eric T. Moolchan; Marilyn A Huestis
Opioid disposition in human sweat after controlled oral codeine administration.
Clinical chemistry 2006;52(8):1539-45.
2006: Edward J Cone
Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
Drug and alcohol dependence 2006;83 Suppl 1():S31-9.
2006: Wonkyung Yang; Allan J Barnes; MARY RIPPLE; David R Fowler; Edward J Cone; Eric T. Moolchan; Heesun Chung; Marilyn A Huestis
Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;833(2):210-8.
2006: Edward J Cone
Oral fluid testing: new technology enables drug testing without embarrassment.
Journal of the California Dental Association 2006;34(4):311-5.
2006: Rachel R McCusker; Bruce A Goldberger; Edward J Cone
Caffeine content of energy drinks, carbonated sodas, and other beverages.
Journal of analytical toxicology 2006;30(2):112-4.
2006: Edward J Cone; Howard A Heit; Yale H Caplan; Douglas L Gourlay
Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine.
Journal of analytical toxicology 2006;30(1):1-5.
2005: Sherri L Kacinko; Allan J Barnes; Eugene W Schwilke; Edward J Cone; Eric T. Moolchan; Marilyn A Huestis
Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.
Clinical chemistry 2005;51(11):2085-94.
2005: R Sam Niedbala; Keith Kardos; Dean Fritch; Kenneth P Kunsman; Kristen A Blum; Gregory A Newland; Joe Waga; Lisa Kurtz; Matth Bronsgeest; Edward J Cone
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Journal of analytical toxicology 2005;29(7):607-15.
2005: Gilberto N Carmona; Charles W Schindler; Nigel H Greig; Harold W Holloway; Rebecca A Jufer; Edward J Cone; David A Gorelick
Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats.
European journal of pharmacology 2005;517(3):186-90.
2005: Amanda J Jenkins; Jack E Henningfield; Edward J Cone
Relationship between plasma and oral fluid nicotine concentrations in humans: a pilot study.
Therapeutic drug monitoring 2005;27(3):345-8.
2005: Karl B Scheidweiler; Edward J Cone; Eric T. Moolchan; Marilyn A Huestis
Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration.
The Journal of pharmacology and experimental therapeutics 2005;313(2):909-15.
2004: Insook Kim; Jonathan M Oyler; Eric T. Moolchan; Edward J Cone; Marilyn A Huestis
Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans.
Therapeutic drug monitoring 2004;26(6):664-72.
2004: Edward J Cone; Reginald V Fant; Jeffrey M Rohay; Yale H Caplan; Mayra Ballina; Robert F Reder; J David Haddox
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
Journal of analytical toxicology 2004;28(7):616-24.
2004: Sam Niedbala; Keith Kardos; Sal Salamone; Dean Fritch; Matth Bronsgeest; Edward J Cone
Passive cannabis smoke exposure and oral fluid testing.
Journal of analytical toxicology 2004;28(7):546-52.
2004: ANNIE UMBRICHT; Marilyn A Huestis; Edward J Cone; Kenzie L. Preston
Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
Journal of clinical psychopharmacology 2004;24(5):479-87.
2004: Marilyn A Huestis; Edward J Cone
Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Journal of analytical toxicology 2004;28(6):394-9.
2004: Edward J Cone; Reginald V Fant; Jeffrey M Rohay; Yale H Caplan; Mayra Ballina; Robert F Reder; J David Haddox
Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
Journal of analytical toxicology 2004;28(4):217-25.
2003: Rachel R McCusker; Bruce A Goldberger; Edward J Cone
Caffeine content of specialty coffees.
Journal of analytical toxicology 2003;27(7):520-2.
2003: Edward J Cone; Angela H Sampson-Cone; William D Darwin; Marilyn A Huestis; Jonathan M Oyler
Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
Journal of analytical toxicology 2003;27(7):386-401.
2003: Lance Presley; Michael Lehrer; William Seiter; Dawn Hahn; Barbara Rowland; Melissa Smith; Keith Kardos; Dean Fritch; Sal Salamone; R Sam Niedbala; Edward J Cone
High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.
Forensic science international 2003;133(1-2):22-5.
2003: Edward J Cone; Reginald V Fant; Jeffrey M Rohay; Yale H Caplan; Mayra Ballina; Robert F Reder; Daniel Spyker; J David Haddox
Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.
Journal of analytical toxicology 2003;27(2):57-67; discussion 67.
2003: Raf Schepers; Jonathan M Oyler; Robert E Joseph; Edward J Cone; Eric T. Moolchan; Marilyn A Huestis
Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
Clinical chemistry 2003;49(1):121-32.
2002: Edward J Cone; Lance Presley; Michael Lehrer; William Seiter; Melissa Smith; Keith Kardos; Dean Fritch; Sal Salamone; R Sam Niedbala
Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
Journal of analytical toxicology 2002;26(8):541-6.
2002: Kenzie L. Preston; David H Epstein; Edward J Cone; Abraham Wtsadik; Marilyn A Huestis; Eric T. Moolchan
Urinary elimination of cocaine metabolites in chronic cocaine users during cessation.
Journal of analytical toxicology 2002;26(7):393-400.
2002: Amanda J Jenkins; Robert M Keenan; Jack E Henningfield; Edward J Cone
Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration.
Journal of analytical toxicology 2002;26(7):382-92.
2002: Jonathan M Oyler; Edward J Cone; Robert E Joseph; Eric T. Moolchan; Marilyn A Huestis
Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans.
Clinical chemistry 2002;48(10):1703-14.
2002: Insook Kim; Allan J Barnes; Jonathan M Oyler; Raf Schepers; Robert E Joseph; Edward J Cone; Diana Lafko; Eric T. Moolchan; Marilyn A Huestis
Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.
Clinical chemistry 2002;48(9):1486-96.
2002: Edward J Cone; Kenzie L. Preston
Toxicologic aspects of heroin substitution treatment.
Therapeutic drug monitoring 2002;24(2):193-8.
2001: Michael L Smith; Eric Shimomura; J Summers; Buddha D Paul; Amanda J Jenkins; William D Darwin; Edward J Cone
Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
Journal of analytical toxicology 2001;25(7):504-14.
2001: Edward J Cone
Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale.
Forensic science international 2001;121(1-2):7-15.
2001: R Sam Niedbala; Keith Kardos; Dean Fritch; S Kardos; T Fries; Joe Waga; J Robb; Edward J Cone
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
Journal of analytical toxicology 2001;25(5):289-303.
2001: Rolley E. Johnson; Hendrée E Jones; Donald R Jasinski; Dace S. Svikis; Nancy A Haug; Lauren M Jansson; Wendy B Kissin; G Alpan; Michael Edward Lantz; Edward J Cone; Diana G Wilkins; Archie Golden; George Huggins; B M Lester
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes.
Drug and alcohol dependence 2001;63(1):97-103.
2000: Jonathan M Oyler; Edward J Cone; Robert E Joseph; Marilyn A Huestis
Identification of hydrocodone in human urine following controlled codeine administration.
Journal of analytical toxicology 2000;24(7):530-5.
2000: Michael L Smith; Eric Shimomura; J Summers; Buddha D Paul; D Nichols; R Shippee; Amanda J Jenkins; William D Darwin; Edward J Cone
Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.
Journal of analytical toxicology 2000;24(7):522-9.
2000: Marilyn A Huestis; Edward J Cone; Conrad Jung Liang Wong; ANNIE UMBRICHT; Kenzie L. Preston
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Journal of analytical toxicology 2000;24(7):509-21.
2000: Jeri D Ropero-Miller; Bruce A Goldberger; Edward J Cone; Robert E Joseph
The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administration.
Journal of analytical toxicology 2000;24(7):496-508.
2000: Rebecca A Jufer; AT Wstadik; S L Walsh; Barry S Levine; Edward J Cone
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
Journal of analytical toxicology 2000;24(7):467-77.
2000: Eric T. Moolchan; Edward J Cone; AT Wstadik; Marilyn A Huestis; Kenzie L. Preston
Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.
Journal of analytical toxicology 2000;24(7):458-66.
2000: Gilberto N Carmona; Rebecca A Jufer; Steven R Goldberg; David A Gorelick; Nigel H Greig; Qian-Sheng Yu; Edward J Cone; Charles W Schindler
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(3):367-71.
2000: Elias Robles; Kenneth Silverman; Kenzie L. Preston; Edward J Cone; E Katz; George E Bigelow; Maxine L Stitzer
The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
Drug and alcohol dependence 2000;58(1-2):205-12.
1999: Marilyn A Huestis; Jonathan M Oyler; Edward J Cone; AT Wstadik; D Schoendorfer; Robert E Joseph
Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1999;733(1-2):247-64.
1999: Diana G Wilkins; Douglas E Rollins; AS Valdez; Atsuhiro Mizuno; Gerald G Krueger; Edward J Cone
A retrospective study of buprenorphine and norbuprenorphine in human hair after multiple doses.
Journal of analytical toxicology 1999;23(6):409-15.
1999: Robert E Joseph; KM Höld; Diana G Wilkins; Douglas E Rollins; Edward J Cone
Drug testing with alternative matrices II. Mechanisms of cocaine and codeine deposition in hair.
Journal of analytical toxicology 1999;23(6):396-408.
1999: Kenzie L. Preston; Marilyn A Huestis; Conrad Jung Liang Wong; ANNIE UMBRICHT; Bruce A Goldberger; Edward J Cone
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
Journal of analytical toxicology 1999;23(5):313-22.
1999: Marc A LeBeau; W Andollo; W Lee Hearn; R Baselt; Edward J Cone; B Finkle; D Fraser; A Jenkins; J Mayer; Adam Negrusz; A Poklis; HC Walls; LP Raymon; M Robertson; J Saady
Recommendations for toxicological investigations of drug-facilitated sexual assaults.
Journal of forensic sciences 1999;44(1):227-30.
1998: Edward J Cone
Recent discoveries in pharmacokinetics of drugs of abuse.
Toxicology letters 1998;102-103():97-101.
1998: Kenzie L. Preston; Bruce A Goldberger; Edward J Cone
Occurrence of cocaine in urine of substance-abuse treatment patients.
Journal of analytical toxicology 1998;22(7):580-6.
1998: Bruce A Goldberger; A G Darraj; Yale H Caplan; Edward J Cone
Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects.
Journal of analytical toxicology 1998;22(6):526-30.
1998: Edward J Cone; R Lange; William D Darwin
In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.
Journal of analytical toxicology 1998;22(6):460-73.
1998: Marilyn A Huestis; Edward J Cone
Differentiating new marijuana use from residual drug excretion in occasional marijuana users.
Journal of analytical toxicology 1998;22(6):445-54.
1998: Rebecca A Jufer; S L Walsh; Edward J Cone
Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.
Journal of analytical toxicology 1998;22(6):435-44.
1998: Marilyn A Huestis; Edward J Cone
Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.
Therapeutic drug monitoring 1998;20(5):570-6.
1998: Edward J Cone; A Tsadik; Jonathan M Oyler; William D Darwin
Cocaine metabolism and urinary excretion after different routes of administration.
Therapeutic drug monitoring 1998;20(5):556-60.
1998: Kenzie L. Preston; Kenneth Silverman; S T Higgins; Robert K Brooner; Ivan Montoya; Charles R Schuster; Edward J Cone
Cocaine use early in treatment predicts outcome in a behavioral treatment program.
Journal of consulting and clinical psychology 1998;66(4):691-6.
1998: Gilberto N Carmona; Charles W Schindler; M Shoaib; Rebecca A Jufer; Edward J Cone; Steven R Goldberg; Nigel H Greig; Qian-Sheng Yu; David A Gorelick
Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.
Experimental and clinical psychopharmacology 1998;6(3):274-9.
1998: Leigh V Panlilio; Steven R Goldberg; Joanne P Gilman; Rebecca A Jufer; Edward J Cone; Charles W Schindler
Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys.
Psychopharmacology 1998;137(3):253-8.
1998: J J Kuhlman; Barry S Levine; Rolley E. Johnson; P J Fudala; Edward J Cone
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
Addiction (Abingdon, England) 1998;93(4):549-59.
1998: Sharon L Walsh; Rolley E. Johnson; Edward J Cone; George E Bigelow
Intravenous and oral l-alpha-acetylmethadol: pharmacodynamics and pharmacokinetics in humans.
The Journal of pharmacology and experimental therapeutics 1998;285(1):71-82.
1998: KM Höld; Diana G Wilkins; Douglas E Rollins; Robert E Joseph; Edward J Cone
Simultaneous quantitation of cocaine, opiates, and their metabolites in human hair by positive ion chemical ionization gas chromatography-mass spectrometry.
Journal of chromatographic science 1998;36(3):125-30.
1998: Robert E Joseph; Jonathan M Oyler; AT Wstadik; C Ohuoha; Edward J Cone
Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum.
Journal of analytical toxicology 1998;22(1):6-17.
1997: Edward J Cone; Jonathan M Oyler; William D Darwin
Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.
Journal of analytical toxicology 1997;21(6):465-75.
1997: Robert E Joseph; W J Tsai; Li-I Tsao; Tsung-Ping Su; Edward J Cone
In vitro characterization of cocaine binding sites in human hair.
The Journal of pharmacology and experimental therapeutics 1997;282(3):1228-41.
1997: Kenzie L. Preston; Kenneth Silverman; Charles R Schuster; Edward J Cone
Assessment of cocaine use with quantitative urinalysis and estimation of new uses.
Addiction (Abingdon, England) 1997;92(6):717-27.
1997: Diana Garside; Bruce A Goldberger; Kenzie L. Preston; Edward J Cone
Rapid liquid-liquid extraction of cocaine from urine for gas chromatographic-mass spectrometric analysis.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):61-5.
1997: Gisela Skopp; Beate Ganssmann; Edward J Cone; Rolf Aderjan
Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration.
Journal of analytical toxicology 1997;21(2):105-11.
1997: Kenzie L. Preston; Kenneth Silverman; Charles R Schuster; Edward J Cone
Use of quantitative urinalysis in monitoring cocaine use.
NIDA research monograph 1997;175():253-64.
1997: Kenzie L. Preston; Kenneth Silverman; Charles R Schuster; Edward J Cone
Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies.
NIDA research monograph 1997;167():130-45.
1997: Edward J Cone
New developments in biological measures of drug prevalence.
NIDA research monograph 1997;167():108-29.
1996: S M Evans; Edward J Cone; Jack E Henningfield
Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.
The Journal of pharmacology and experimental therapeutics 1996;279(3):1345-56.
1996: Jonathan M Oyler; William D Darwin; Kenzie L. Preston; P Suess; Edward J Cone
Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users.
Journal of analytical toxicology 1996;20(6):453-62.
1996: Marilyn A Huestis; J M Mitchell; Edward J Cone
Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
Journal of analytical toxicology 1996;20(6):441-52.
1996: Edward J Cone; Rebecca A Jufer; William D Darwin; S B Needleman
Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin.
Journal of analytical toxicology 1996;20(6):379-92.
1996: Robert E Joseph; Tsung-Ping Su; Edward J Cone
In vitro binding studies of drugs to hair: influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair.
Journal of analytical toxicology 1996;20(6):338-44.
1996: B A Goldberger; Edward J Cone; L Kadehjian
Unsuspected ethanol ingestion through soft drinks and flavored beverages.
Journal of analytical toxicology 1996;20(5):332-3.
1996: Edward J Cone
Mechanisms of drug incorporation into hair.
Therapeutic drug monitoring 1996;18(4):438-43.
1996: J J Kuhlman; J Magluilo; Edward J Cone; Barry S Levine
Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry.
Journal of analytical toxicology 1996;20(4):229-35.
1996: Jonathan M Oyler; William D Darwin; Edward J Cone
Cocaine contamination of United States paper currency.
Journal of analytical toxicology 1996;20(4):213-6.
1996: Kenneth Silverman; S T Higgins; Robert K Brooner; Ivan Montoya; Edward J Cone; Charles R Schuster; Kenzie L. Preston
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
Archives of general psychiatry 1996;53(5):409-15.
1996: S P Gygi; Robert E Joseph; Edward J Cone; D G Wilkins; Douglas E Rollins
Incorporation of codeine and metabolites into hair. Role of pigmentation.
Drug metabolism and disposition: the biological fate of chemicals 1996;24(4):495-501.
1996: Edward J Cone; K Kato; M Hillsgrove
Cocaine excretion in the semen of drug users.
Journal of analytical toxicology 1996;20(2):139-40.
1996: A J Jenkins; T Llosa; Ivan Montoya; Edward J Cone
Identification and quantitation of alkaloids in coca tea.
Forensic science international 1996;77(3):179-89.
1996: G N Carmona; I Baum; Charles W Schindler; Steven R Goldberg; Rebecca A Jufer; Edward J Cone; E Slaughter; G W Belendiuk; David A Gorelick
Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys.
Life sciences 1996;59(11):939-43.
1995: R H Liu; G Foster; Edward J Cone; S D Kumar
Selecting an appropriate isotopic internal standard for gas chromatography/mass spectrometry analysis of drugs of abuse--pentobarbital example.
Journal of forensic sciences 1995;40(6):983-9.
1995: D Wilkins; HM Haughey; Edward J Cone; M Huestis; Rodger L Foltz; D Rollins
Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry.
Journal of analytical toxicology 1995;19(6):483-91.
1995: Edward J Cone
Pharmacokinetics and pharmacodynamics of cocaine.
Journal of analytical toxicology 1995;19(6):459-78.
1995: Marilyn A Huestis; J M Mitchell; Edward J Cone
Detection times of marijuana metabolites in urine by immunoassay and GC-MS.
Journal of analytical toxicology 1995;19(6):443-9.
1995: Edward J Cone; D Yousefnejad; M J Hillsgrove; B Holicky; William D Darwin
Passive inhalation of cocaine.
Journal of analytical toxicology 1995;19(6):399-411.
1995: A J Jenkins; Jonathan M Oyler; Edward J Cone
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.
Journal of analytical toxicology 1995;19(6):359-74.
1995: Harry L June; Maxine L Stitzer; Edward J Cone
Acute physical dependence: time course and relation to human plasma morphine concentrations.
Clinical pharmacology and therapeutics 1995;57(3):270-80.
1995: W L Wang; Edward J Cone
Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects.
Forensic science international 1995;70(1-3):39-51.
1995: Bruce A Goldberger; B Loewenthal; William D Darwin; Edward J Cone
Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of heroin users.
Clinical chemistry 1995;41(1):116-7.
1995: A J Jenkins; William D Darwin; Marilyn A Huestis; Edward J Cone; J M Mitchell
Validity testing of the accuPINCH THC test.
Journal of analytical toxicology 1995;19(1):5-12.
1995: R Joseph; S Dickerson; R Willis; D Frankenfield; Edward J Cone; D R Smith
Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
Journal of analytical toxicology 1995;19(1):13-7.
1995: Michael L Smith; R O Hughes; Barry S Levine; S Dickerson; W D Darwin; Edward J Cone
Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Journal of analytical toxicology 1995;19(1):18-26.
1994: W L Wang; William D Darwin; Edward J Cone
Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical applications 1994;660(2):279-90.
1994: A J Jenkins; R M Keenan; Jack E Henningfield; Edward J Cone
Pharmacokinetics and pharmacodynamics of smoked heroin.
Journal of analytical toxicology 1994;18(6):317-30.
1994: Edward J Cone; M J Hillsgrove; A J Jenkins; R M Keenan; William D Darwin
Sweat testing for heroin, cocaine, and metabolites.
Journal of analytical toxicology 1994;18(6):298-305.
1994: Bruce A Goldberger; Edward J Cone
Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
Journal of chromatography. A 1994;674(1-2):73-86.
1994: Edward J Cone; M Hillsgrove; William D Darwin
Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry.
Clinical chemistry 1994;40(7 Pt 1):1299-305.
1994: Sharon L Walsh; Kenzie L. Preston; Maxine L Stitzer; Edward J Cone; George E Bigelow
Clinical pharmacology of buprenorphine: ceiling effects at high doses.
Clinical pharmacology and therapeutics 1994;55(5):569-80.
1994: Marilyn A Huestis; J M Mitchell; Edward J Cone
Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
Clinical chemistry 1994;40(5):729-33.
1994: Terrence P O'Brien; CA Gleason; M D Jones; Edward J Cone; E D London; Richard J Traystman
Cerebral responses to single and multiple cocaine injections in newborn sheep.
Pediatric research 1994;35(3):339-43.
1994: Bruce A Goldberger; Edward J Cone; T M Grant; Y H Caplan; Barry S Levine; John E Smialek
Disposition of heroin and its metabolites in heroin-related deaths.
Journal of analytical toxicology 1994;18(1):22-8.
1993: Edward J Cone; William D Darwin; W L Wang
The occurrence of cocaine, heroin and metabolites in hair of drug abusers.
Forensic science international 1993;63(1-3):55-68.
1993: Edward J Cone; Marilyn A Huestis
Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.
Therapeutic drug monitoring 1993;15(6):527-32.
1993: K Kato; M Hillsgrove; L Weinhold; D A Gorelick; William D Darwin; Edward J Cone
Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.
Journal of analytical toxicology 1993;17(6):338-41.
1993: Edward J Cone; B A Holicky; T M Grant; William D Darwin; Bruce A Goldberger
Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin.
Journal of analytical toxicology 1993;17(6):327-37.
1993: Edward J Cone
Saliva testing for drugs of abuse.
Annals of the New York Academy of Sciences 1993;694():91-127.
1993: W L Wang; Edward J Cone; J Zacny
Immunoassay evidence for fentanyl in hair of surgery patients.
Forensic science international 1993;61(1):65-72.
1993: A J Jenkins; L C Mills; William D Darwin; Marilyn A Huestis; Edward J Cone; J M Mitchell
Validity testing of the EZ-SCREEN cannabinoid test.
Journal of analytical toxicology 1993;17(5):292-8.
1993: C A Gleason; H Iida; Terrence P O'Brien; M D Jones; Edward J Cone; Richard J Traystman
Fetal responses to acute maternal cocaine injection in sheep.
The American journal of physiology 1993;265(1 Pt 2):H9-14.
1993: Wallace B Pickworth; Rolley E. Johnson; B A Holicky; Edward J Cone
Subjective and physiologic effects of intravenous buprenorphine in humans.
Clinical pharmacology and therapeutics 1993;53(5):570-6.
1993: Edward J Cone; Marilyn A Huestis; J M Mitchell
Do consecutive urine catches differ in marijuana metabolite concentration?
Journal of analytical toxicology 1993;17(3):186-7.
1993: Edward J Cone; S Dickerson; B D Paul; J M Mitchell
Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays.
Journal of analytical toxicology 1993;17(3):156-64.
1993: Bruce A Goldberger; William D Darwin; T M Grant; A C Allen; Y H Caplan; Edward J Cone
Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry.
Clinical chemistry 1993;39(4):670-5.
1992: Edward J Cone; William D Darwin
Rapid assay of cocaine, opiates and metabolites by gas chromatography-mass spectrometry.
Journal of chromatography 1992;580(1-2):43-61.
1992: Marilyn A Huestis; Jack E Henningfield; Edward J Cone
Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)
Journal of analytical toxicology 1992;16(5):283-90.
1992: Marilyn A Huestis; Jack E Henningfield; Edward J Cone
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Journal of analytical toxicology 1992;16(5):276-82.
1992: Marilyn A Huestis; A H Sampson; B J Holicky; Jack E Henningfield; Edward J Cone
Characterization of the absorption phase of marijuana smoking.
Clinical pharmacology and therapeutics 1992;52(1):31-41.
1992: S T Higgins; Kenzie L. Preston; Edward J Cone; Jack E Henningfield; Jerome H Jaffe
Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
Drug and alcohol dependence 1992;30(1):13-26.
1992: Nancy K Mello; Scott E Lukas; J B Kamien; Jack H Mendelson; J Drieze; Edward J Cone
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1185-93.
1992: Edward J Cone; S Dickerson; B D Paul; J M Mitchell
Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays.
Journal of analytical toxicology 1992;16(2):72-8.
1992: Edward J Cone; S L Dickerson
Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence.
NIDA research monograph 1992;128():46-58; discussion 59-63.
1991: Tsung-Ping Su; X Z Wu; Edward J Cone; K Shukla; T M Gund; A L Dodge; D W Parish
Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand.
The Journal of pharmacology and experimental therapeutics 1991;259(2):543-50.
1991: Edward J Cone; D Yousefnejad; William D Darwin; T Maguire
Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures.
Journal of analytical toxicology 1991;15(5):250-5.
1991: Bruce A Goldberger; Y H Caplan; T Maguire; Edward J Cone
Testing human hair for drugs of abuse. III. Identification of heroin and 6-acetylmorphine as indicators of heroin use.
Journal of analytical toxicology 1991;15(5):226-31.
1991: Edward J Cone; P Welch; B D Paul; J M Mitchell
Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration.
Journal of analytical toxicology 1991;15(4):161-6.
1991: J M Mitchell; B D Paul; P Welch; Edward J Cone
Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration.
Journal of analytical toxicology 1991;15(2):49-53.
1991: Wallace B Pickworth; E Bunker; P Welch; Edward J Cone
Intravenous buprenorphine reduces pupil size and the light reflex in humans.
Life sciences 1991;49(2):129-38.
1991: Edward J Cone; P Welch; J M Mitchell; B D Paul
Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times.
Journal of analytical toxicology 1991;15(1):1-7.
1991: D Bruce Vaupel; Edward J Cone
Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity.
The Journal of pharmacology and experimental therapeutics 1991;256(1):211-21.
1990: STEPHEN HEISHMAN; Marilyn A Huestis; Jack E Henningfield; Edward J Cone
Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.
Pharmacology, biochemistry, and behavior 1990;37(3):561-5.
1990: W W Weddington; B S Brown; C A Haertzen; Edward J Cone; E M Dax; Ronald I Herning; B S Michaelson
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study.
Archives of general psychiatry 1990;47(9):861-8.
1990: William Furman; Andrew M Munster; Edward J Cone
Morphine pharmacokinetics during anesthesia and surgery in patients with burns.
The Journal of burn care & rehabilitation 1990;11(5):391-4.
1990: Edward J Cone; D Yousefnejad; S L Dickerson
Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
Journal of forensic sciences 1990;35(4):786-91.
1990: Michael J Kuhar; J W Boja; Edward J Cone
Phencyclidine binding to striatal cocaine receptors.
Neuropharmacology 1990;29(3):295-7.
1990: W R Lange; Edward J Cone; F R Snyder
The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987.
Archives of internal medicine 1990;150(2):365-8.
1990: Edward J Cone
Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug-induced effects on pupils and behavior.
Journal of analytical toxicology 1990;14(1):1-7.
1990: M C Ritz; Edward J Cone; Michael J Kuhar
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.
Life sciences 1990;46(9):635-45.
1990: Edward J Cone
Marijuana effects and urinalysis after passive inhalation and oral ingestion.
NIDA research monograph 1990;99():88-96.
1990: D Bruce Vaupel; Edward J Cone; Rolley E. Johnson; Tsung-Ping Su
Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
The Journal of pharmacology and experimental therapeutics 1990;252(1):225-34.
1990: Edward J Cone; S L Dickerson; William D Darwin; Paul J Fudala; Rolley E. Johnson
Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine.
NIDA research monograph 1990;105():569.
1990: W W Weddington; B S Brown; Edward J Cone; C A Haertzen; E M Dax; Ronald I Herning; B S Michaelson
Changes in mood, craving and sleep during acute abstinence reported by male cocaine addicts.
NIDA research monograph 1990;105():453-4.
1989: Wallace B Pickworth; P Welch; Jack E Henningfield; Edward J Cone
Opiate-induced pupillary effects in humans.
Methods and findings in experimental and clinical pharmacology 1989;11(12):759-63.
1989: Rolley E. Johnson; Edward J Cone; Jack E Henningfield; Paul J Fudala
Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction.
Clinical pharmacology and therapeutics 1989;46(3):335-43.
1989: A Della Puppa; F Ford-Rice; F R Snyder; Edward J Cone; Edythe D London
Time course of verapamil interaction with morphine effects on physiological parameters in rats.
The Journal of pharmacy and pharmacology 1989;41(9):617-23.
1989: Edward J Cone
Validity testing of commercial urine cocaine metabolite assays: III. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for detection of cocaine and cocaine metabolite.
Journal of forensic sciences 1989;34(4):991-5.
1989: W R Lange; J C Ball; M B Pfeiffer; F R Snyder; Edward J Cone
The Lexington addicts, 1971-1972: demographic characteristics, drug use patterns, and selected infectious disease experience.
The International journal of the addictions 1989;24(7):609-26.
1989: K M Kumor; M A Sherer; J Gomez; Edward J Cone; Jerome H Jaffe
Subjective response during continuous infusion of cocaine.
Pharmacology, biochemistry, and behavior 1989;33(2):443-52.
1989: Edward J Cone; W W Weddington
Prolonged occurrence of cocaine in human saliva and urine after chronic use.
Journal of analytical toxicology 1989;13(2):65-8.
1989: Edward J Cone; Jack E Henningfield
Premier 'smokeless cigarettes' can be used to deliver crack.
JAMA : the journal of the American Medical Association 1989;261(1):41.
1989: Edward J Cone; J Mitchell
Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by gas chromatography/mass spectrometry.
Journal of forensic sciences 1989;34(1):32-45.
1989: Edward J Cone; S L Menchen; B D Paul; L D Mell; J Mitchell
Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.
Journal of forensic sciences 1989;34(1):15-31.
1989: Paul J Fudala; Rolley E. Johnson; STEPHEN HEISHMAN; Edward J Cone; Jack E Henningfield
A dose run-up and safety evaluation of nalmefene HCl in human volunteers.
NIDA research monograph 1989;95():451-2.
1989: Edward J Cone; P Welch
Time course of detection of 6-acetylmorphine in urine after heroin administration.
NIDA research monograph 1989;95():449.
1988: Edward J Cone; S L Menchen
Stability of cocaine in saliva.
Clinical chemistry 1988;34(7):1508.
1988: M A Sherer; K M Kumor; Edward J Cone; Jerome H Jaffe
Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings.
Archives of general psychiatry 1988;45(7):673-7.
1988: Edward J Cone; K Kumor; L K Thompson; M Sherer
Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects.
Journal of analytical toxicology 1988;12(4):200-6.
1988: Edward J Cone; Rolley E. Johnson; B D Paul; L D Mell; J Mitchell
Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion.
Journal of analytical toxicology 1988;12(4):169-75.
1988: Edward J Cone; S L Menchen; J Mitchell
Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.
Forensic science international 1988;37(4):265-75.
1988: Peyton Jacob; N L Benowitz; J R Copeland; M E Risner; Edward J Cone
Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogs.
Journal of pharmaceutical sciences 1988;77(5):396-400.
1988: M E Risner; Edward J Cone; N L Benowitz; P Jacob
Effects of the stereoisomers of nicotine and nornicotine on schedule-controlled responding and physiological parameters of dogs.
The Journal of pharmacology and experimental therapeutics 1988;244(3):807-13.
1988: Edward J Cone; P Welch; W R Lange
Clonidine partially blocks the physiologic effects but not the subjective effects produced by smoking marijuana in male human subjects.
Pharmacology, biochemistry, and behavior 1988;29(3):649-52.
1988: K Kumor; M Sherer; L Thompson; Edward J Cone; J Mahaffey; Jerome H Jaffe
Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers.
Life sciences 1988;42(21):2063-71.
1988: S Higgins; Kenzie L. Preston; Edward J Cone; Jack E Henningfield; Jerome H Jaffe
Behavioral, physiological and hormonal effects of a naloxone challenge following acute morphine pretreatment in humans.
NIDA research monograph 1988;81():202-8.
1987: Edward J Cone; S L Menchen
Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.
Journal of analytical toxicology 1987;11(6):276-7.
1987: L K Thompson; Edward J Cone
Determination of delta 9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection.
Journal of chromatography 1987;421(1):91-7.
1987: Edward J Cone; Rolley E. Johnson; William D Darwin; D Yousefnejad; L D Mell; B D Paul; J Mitchell
Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Journal of analytical toxicology 1987;11(3):89-96.
1987: L K Thompson; D Yousefnejad; K Kumor; M Sherer; Edward J Cone
Confirmation of cocaine in human saliva after intravenous use.
Journal of analytical toxicology 1987;11(1):36-8.
1987: Edward J Cone; John D Roache; Rolley E. Johnson
Effects of passive exposure to marijuana smoke.
NIDA research monograph 1987;76():150-6.
1986: Edward J Cone; D Yousefnejad; W D Buchwald; K Kumor
Determination of ketocyclazocine in human plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry.
Journal of chromatography 1986;383(1):158-65.
1986: Kenzie L. Preston; Roland R Griffiths; Edward J Cone; William D Darwin; C W Gorodetzky
Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.
Drug and alcohol dependence 1986;18(2):195-202.
1986: Edward J Cone; Rolley E. Johnson
Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Clinical pharmacology and therapeutics 1986;40(3):247-56.
1986: Edward J Cone; Rolley E. Johnson; J D Moore; John D Roache
Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects.
Pharmacology, biochemistry, and behavior 1986;24(6):1749-54.
1986: J D Moore; Edward J Cone; S S Alexander
HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives for evidence of viral exposure?
The New England journal of medicine 1986;314(21):1387-8.
1986: M E Risner; Edward J Cone
Intravenous self-administration of fencamfamine and cocaine by beagle dogs under fixed-ratio and progressive-ratio schedules of reinforcement.
Drug and alcohol dependence 1986;17(1):93-102.
1985: M E Risner; P A Jackson-Smith; Edward J Cone
Discriminative stimulus properties and schedule effects of fencamfamine in rats.
Pharmacology, biochemistry, and behavior 1985;23(3):449-56.
1985: M E Risner; S R Goldberg; J A Prada; Edward J Cone
Effects of nicotine, cocaine and some of their metabolites on schedule-controlled responding by beagle dogs and squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 1985;234(1):113-9.
1985: Edward J Cone; C W Gorodetzky; D Yousefnejad; William D Darwin
63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces.
Journal of chromatography 1985;337(2):291-300.
1984: Edward J Cone; C W Gorodetzky; D Yousefnejad; W F Buchwald; Rolley E. Johnson
The metabolism and excretion of buprenorphine in humans.
Drug metabolism and disposition: the biological fate of chemicals 1984;12(5):577-81.
1984: D B Vaupel; D McCoun; Edward J Cone
Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.
The Journal of pharmacology and experimental therapeutics 1984;230(1):20-7.
1984: H E Shannon; Edward J Cone; C W Gorodetzky
Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
The Journal of pharmacology and experimental therapeutics 1984;229(3):768-74.
1984: C W Gorodetzky; Edward J Cone; Rolley E. Johnson; M E Risner; Tsung-Ping Su; S Y Yeh
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky.
NIDA research monograph 1984;49():63-8.
1984: Edward J Cone; C W Gorodetzky; William D Darwin; W F Buchwald
Stability of the 6,14-endo-ethanotetrahydrooripavine analgesics: acid-catalyzed rearrangement of buprenorphine.
Journal of pharmaceutical sciences 1984;73(2):243-6.
1984: Edward J Cone; R L McQuinn; H E Shannon
Structure-activity relationship studies of phencyclidine derivatives in rats.
The Journal of pharmacology and experimental therapeutics 1984;228(1):147-53.
1984: C W Gorodetzky; W F Buchwald; Edward J Cone; William D Darwin; Wallace B Pickworth; M E Risner; L G Sharpe
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky (1984).
NIDA research monograph 1984;55():52-8.
1983: Edward J Cone; William D Darwin; W F Buchwald; C W Gorodetzky
Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
Drug metabolism and disposition: the biological fate of chemicals 1983;11(5):446-50.
1983: Edward J Cone; William D Darwin; W F Buchwald
Assay for codeine, morphine and ten potential urinary metabolites by gas chromatography--mass fragmentography.
Journal of chromatography 1983;275(2):307-18.
1983: C W Gorodetzky; Edward J Cone; S R Goldberg; S Herling; M E Risner; H E Shannon; D Bruce Vaupel
Progress report from the NIDA Addiction Research Center (preclinical laboratory), Lexington, Kentucky.
NIDA research monograph 1983;43():85-91.
1983: H E Shannon; R L McQuinn; D Bruce Vaupel; Edward J Cone
Effects of cycloalkyl ring analogs of phencyclidine on behavior in rodents.
The Journal of pharmacology and experimental therapeutics 1983;224(2):327-33.
1982: Edward J Cone; W F Buchwald; William D Darwin
Analytical controls in drug metabolic studies. II. Artifact formation during chloroform extraction of drugs and metabolites with amine substituents.
Drug metabolism and disposition: the biological fate of chemicals 1982;10(6):561-7.
1982: H E Shannon; Edward J Cone; D Yousefnejad
Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog.
The Journal of pharmacology and experimental therapeutics 1982;223(1):190-6.
1982: Edward J Cone; C W Gorodetzky; S Y Yeh; William D Darwin; W F Buchwald
Detection and measurement of opium alkaloids and metabolites in urine of opium eaters by methane chemical ionization mass fragmentography.
Journal of chromatography 1982;230(1):57-67.
1982: C W Gorodetzky; Edward J Cone; J L Croughan; S R Goldberg; M E Risner; H E Shannon; Tsung-Ping Su; S Y Yeh
Progress report from the NIDA Addiction Research Center (Preclinical Laboratory), Lexington, Ky.
NIDA research monograph 1982;41():53-9.
1982: Edward J Cone; H Shannon; B Vaupel; Tsung-Ping Su; R McQuinn
A structure activity relationship study of the cyclohexyl and aromatic rings of phencyclidine (PCP).
NIDA research monograph 1982;41():126-33.
1982: Edward J Cone; D B Vaupel; D Yousefnejad
Monohydroxymetabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse.
The Journal of pharmacy and pharmacology 1982;34(3):197-9.
1981: R L McQuinn; Edward J Cone; H E Shannon; Tsung-Ping Su
Structure-activity relationships of the cycloalkyl ring of phencyclidine.
Journal of medicinal chemistry 1981;24(12):1429-32.
1981: Frank carroll; G A Brine; K G Boldt; Edward J Cone; D Yousefnejad; D B Vaupel; W F Buchwald
Phencyclidine metabolism: resolution, structure, and biological activity of the isomers of the hydroxy metabolite, 4-phenyl-4-(1-piperidinyl)cyclohexanol.
Journal of medicinal chemistry 1981;24(9):1047-51.
1981: Edward J Cone; W Buchwald; D Yousefnejad
Simultaneous determination of phencyclidine and monohydroxylated metabolites in urine of man by gas chromatography-mass fragmentography with methane chemical ionization.
Journal of chromatography 1981;223(2):331-9.
1981: H E Shannon; Edward J Cone; D Yousefnejad
Physiologic effects and plasma kinetics of phenylethanolamine and its N-methyl homolog in the dog.
The Journal of pharmacology and experimental therapeutics 1981;217(2):379-85.
1981: D B Vaupel; Edward J Cone
A pharmacologic comparison between phencyclidine, its precursor, metabolites, and a quaternary derivative in the dog.
NIDA research monograph 1981;34():180-6.
1980: Donald R Jasinski; H E Shannon; D Bruce Vaupel; Edward J Cone; M E Risner; R L McQuinn; Tsung-Ping Su; Wallace B Pickworth
Interdisciplinary studies on phencyclidine at the Addiction Research Center, Lexington, Kentucky [proceedings].
Psychopharmacology bulletin 1980;16(4):79-81.
1980: Edward J Cone; D B Vaupel; W F Buchwald
Phencyclidine: Detection and measurement of toxic precursors and analogs in lllicit samples.
Journal of analytical toxicology 1980;4(3):119-23.
1980: W D Darwin; Edward J Cone
Fluorescence properties of pseudomorphine and congeners: structure-activity relationships.
Journal of pharmaceutical sciences 1980;69(3):253-7.
1980: H E Shannon; D Bruce Vaupel; M E Risner; Edward J Cone
Pharmacology of phenethylamine trace amines in the dog--discussion.
Psychopharmacology bulletin 1980;16(1):54-5.
1979: Edward J Cone; W D Darwin; D Yousefnejad; W F Buchwald
Separation and identification of phencyclidine precursors, metabolites and analogs by gas and thin-layer chromatography and chemical ionization mass spectrometry.
Journal of chromatography 1979;177(1):149-53.
1979: Edward J Cone; W D Darwin; C W Gorodetzky
Comparative metabolism of codeine in man, rat, dog, guinea-pig and rabbit: identification of four new metabolites.
The Journal of pharmacy and pharmacology 1979;31(5):314-7.
1979: Donald R Jasinski; Edward J Cone; C W Gorodetzky; M E Risner; H E Shannon; T P Su; D B Vaupel
Progress report from the NIDA Addiction Research Center.
NIDA research monograph 1979;27():61-9.
1978: Edward J Cone; M E Risner; G L Neidert
Concentrations of phenethylamine in dog following single doses and during intravenous self-administration.
Research communications in chemical pathology and pharmacology 1978;22(2):211-32.
1978: Edward J Cone; W D Darwin; C W Gorodetzky; T Tan
Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog.
Drug metabolism and disposition: the biological fate of chemicals 1978;6(4):488-93.
1978: Edward J Cone; C W Gorodetzky; W D Darwin; F I Carroll; G A Brine; C D Welch
The identification and measurement of two new metabolites of naltrexone in human urine.
Research communications in chemical pathology and pharmacology 1978;20(3):413-33.
1978: Edward J Cone
The metabolism of azidomorphine in a human subject.
Xenobiotica; the fate of foreign compounds in biological systems 1978;8(5):301-4.
1978: Edward J Cone; W D Darwin
Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6beta-hydroxy metabolites in urine using selected ion recording with methane chemical ionization.
Biomedical mass spectrometry 1978;5(4):291.
1977: Edward J Cone; B A Phelps; C W Gorodetzky
Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits.
Journal of pharmaceutical sciences 1977;66(12):1709-13.
1976: Edward J Cone
General procedure for the isolation and identification of 6-alpha- and 6-beta-hydroxy metabolites of narcotic agonists and antagonists with a hydromorphone structure.
Journal of chromatography 1976;129():355-61.
1975: Edward J Cone; C W Gorodetzky
Analytical controls in drug metabolic studies. A commentary.
Drug metabolism and disposition: the biological fate of chemicals 1975;3(5):417-8.
1975: Edward J Cone; C W Gorodetzky; S Y Yeh
Biosynthesis, isolation, and identification of 6-beta-hydroxynaltrexone, a major human metabolite of naltrexone.
Journal of pharmaceutical sciences 1975;64(4):618-21.
1974: Edward J Cone; C W Gorodetzky; S Y Yeh
The urinary excretion profile of naltrexone and metabolites in man.
Drug metabolism and disposition: the biological fate of chemicals 1974;2(6):506-12.